Sarah Silbiger/Getty Images North America/Getty Images
FDA Acting Commissioner Dr. Janet Woodcock requested an investigation by the US Department of Health and Human Services Office of Inspector General into the controversial approval of the Alzheimer s disease drug Aduhelm.
By Jamie Gumbrecht, CNN
US Food and Drug Administration Acting Commissioner Dr. Janet Woodcock on Friday requested an investigation by the US Department of Health and Human Services Office of Inspector General into the controversial approval of the Alzheimer’s disease drug Aduhelm.
In a letter posted on Twitter, Woodcock said an independent review and assessment should consider interactions between Biogen, the company that makes Aduhelm, and the FDA during the process that led to the June approval of the drug.
10 July 2021 Coronavirus And Recovery News: Poor Quality Science Being Disseminated In COVID Preprint and Peer-Reviewed Studies
econintersect.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from econintersect.com Daily Mail and Mail on Sunday newspapers.
Acting FDA commissioner calls for independent investigation into approval of Alzheimer s drug
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
MAN W/ALZHEIMER S MARRIES WIFE FOR 2ND TIME (SWEET)
localnews8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from localnews8.com Daily Mail and Mail on Sunday newspapers.
Acting FDA commissioner calls for independent investigation into approval of Alzheimer s drug
channel3000.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from channel3000.com Daily Mail and Mail on Sunday newspapers.